Aristotle University Of Thessaloniki (AUTH)
Μελέτη μοριακών και γενετικών δεικτών σε ασθενείς με καρκίνο του στομάχου
Abstract
dc:descriptionThe optimal adjuvant treatment for gastric cancer remains controversial. We compared the efficacy of a docetaxel and platinum adjuvant chemotherapy regimen in patients with high-risk gastric cancer with that of the same chemotherapy plus radiotherapy. The prognostic value of EGFR, ERCC1, HER2, c-MET/HGFR, MAP-Tau, and PTEN expression was also studied in a subset of 67 patients using immunohistochemistry on tissue microarrays (TMA). Patients with histologically proven, radically resected gastric cancer, stage IB-IV were allocated 6 cycles of docetaxel with cisplatin or Carboplatin AUC5 every 3 weeks (arm A) or the same treatment with radiotherapy (arm B) (4500 cGy). A total of 147 patients were randomised. After a median follow-up of 53.7 months no differences in overall and disease-free survival were found between the two arms. The most common grade 3 and 4 toxicities (excluding alopecia) were neutropenia (11% and 17% respectively), febrile neutropenia (9% and 7%) and diarrhea (7% and 4%). Patients with ERCC1 positive tumors had significantly longer median DFS (33.1 vs. 11.8 months, wald p=0.016) and OS (63.2 vs. 18.8 months, wald p=0.046). None of the other markers had statistically significant value related to OS and DFS. Our results indicate that the addition of radiotherapy to platinum/docetaxel adjuvant therapy does not appear to improve prognosis in high-risk, radically resected gastric cancer. ERCC1 expression and correlation with survival in resected gastric cancer awaits validation in larger groups of patients.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karina, Maria
- Καρίνα, Μαρία
Subjects
dc:subject × 18- Καρκίνος στομάχου
- Ανοσοϊστοχημεία
- Μικροσυστοιχίες
- Συνολική επιβίωση
- Ελεύθερη νόσου επιβίωσης
- Χημειοθεραπεία
- Ακτινοθεραπεία
- Gastric cancer
- Immunohistochemistry (IHC)
- Tissuemicroarrays (TMAs)
- Overall survival (OS)
- Disease free survival (DFS)
- Chemotherapy
- Radiotherapy
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19046